Elevated derived neutrophil-to-lymphocyte ratio corresponds with poor outcome in a patient undergoing pre-operative chemotherapy in a muscle-invasive bladder cancer

Kim van Kessel; Marit de Haan; DE Fransen van de Putte; BWG (Bas) van Rhijn; Ronald de Wit; MS van der Heijden; Ellen Zwarthoff; Joost Boormans

Elevated derived neutrophil-to-lymphocyte ratio corresponds with poor outcome in a patient undergoing pre-operative chemotherapy in a muscle-invasive bladder cancer

Kim van Kessel, Marit de Haan, DE Fransen van de Putte, BWG (Bas) van Rhijn, Ronald de Wit, MS van der Heijden, Ellen Zwarthoff, Joost Boormans

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	351-360
Number of pages	10
Journal	Bladder Cancer
Volume	27
Issue number	2
Publication status	Published - 2016

Research programs

EMC MM-03-24-01
EMC MM-03-49-01

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{eea3026ecbc745f090b29f55726a6e02,

title = "Elevated derived neutrophil-to-lymphocyte ratio corresponds with poor outcome in a patient undergoing pre-operative chemotherapy in a muscle-invasive bladder cancer",

author = "{van Kessel}, Kim and {de Haan}, Marit and {Fransen van de Putte}, DE and {van Rhijn}, {BWG (Bas)} and {de Wit}, Ronald and {van der Heijden}, MS and Ellen Zwarthoff and Joost Boormans",

year = "2016",

language = "Undefined/Unknown",

volume = "27",

pages = "351--360",

journal = "Bladder Cancer",

issn = "2352-3727",

publisher = "SAGE Publications Ltd",

number = "2",

}

TY - JOUR

T1 - Elevated derived neutrophil-to-lymphocyte ratio corresponds with poor outcome in a patient undergoing pre-operative chemotherapy in a muscle-invasive bladder cancer

AU - van Kessel, Kim

AU - de Haan, Marit

AU - Fransen van de Putte, DE

AU - van Rhijn, BWG (Bas)

AU - de Wit, Ronald

AU - van der Heijden, MS

AU - Zwarthoff, Ellen

AU - Boormans, Joost

PY - 2016

Y1 - 2016

M3 - Article

SN - 2352-3727

VL - 27

SP - 351

EP - 360

JO - Bladder Cancer

JF - Bladder Cancer

IS - 2

ER -